ChartRow logo
Share this page
ABBV
$271.36+1.75%
as of close, Oct 7, 2026
☾ AH $271.36 +1.75%
PeersMRNALLYUNHJNJMDTMRK

ABBV — AbbVie Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in ABBV be worth today? →
ABBV returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$271.36
YTD price return
+18.76%
YTD total return
+21.57%
Next earnings
Oct 30, 2026 · Before open
Market cap
479.5B
Enterprise value
536.4B
Shares outstanding
1.8B
52W low
$190.75
52W high
$274.94
From 52W high
-1.30%
From 52W low
+42.26%
52W range
96%
Beta
0.29

Volume

Rel volume
1.27×
30D volume
4.3M
30D $ vol
1.1B

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
−$8.2M
Insider net 1Y
−$18.9M

Form 4 transactions by trade date, as filed; latest on file 2026-08-14.

Fundamentals

Sales (ttm)
64.4B
Sales/share
$36.44
EPS (ttm)
$3.54
FCF (ttm)
18.2B
FCF/share
$10.30
Book value/share
-$3.36
Net margin
9.80%
ROA
4.67%
Current ratio
0.81

Growth (CAGR, ttm) · 10Y

Sales
+10.39%+4.75%+3.69%+10.03%
Net income
+67.74%-10.10%-1.08%+0.99%
FCF
-0.16%-9.78%-1.43%+9.08%
Shares
+0.03%+0.04%-0.00%+0.82%

Per-share growth (CAGR, ttm) · 10Y

EPS
+68.63%-10.02%-0.93%+0.20%
Sales/share
+10.36%+4.70%+3.69%+9.14%
FCF/share
-0.19%-9.82%-1.43%+8.19%
Dividend/share
+5.57%+5.30%+6.44%+11.90%
Price
+16.56%+22.30%+19.61%+15.75%
Total return
+20.18%+26.59%+24.08%+20.60%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
76.7×
P/OI (ttm)
28.4×
Fwd P/E
16.2×
P/S (ttm)
7.4×
P/B (mrq)
-80.8×
P/FCF (ttm)
26.3×
EV/EBITDA (fy)
21.6×
EV/Sales (ttm)
8.3×
FCF yield (ttm)
3.80%
Dividend yield (fwd)
2.55%
Dividend yield (ttm)
2.52%
Dividend/share (fwd)
$6.92
Buyback yield (realized, 1y)
-0.03%
Shareholder yield (realized, 1y)
3.62%
Buyback yield (cash, ttm)
0.31%
Shareholder yield (cash, ttm)
2.81%

Vs own 10Y history

P/E
87th
P/OI
90th
P/S
100th
P/B
97th
P/FCF
100th

Bar = where today’s multiple sits in ABBV’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-07#

1D
+1.75%
5D
+3.73%
1M
+5.81%
3M
+6.56%
YTD
+18.76%
1Y
+16.55%
5Y
+144.76%

Recent filings#

All filings and insider trades →

Financial statements

Open full ABBV financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company+3.42%+2.70%
JNJJohnson & Johnson-6.10%+1.44%
MRKMerck & Co. Inc.-5.02%+0.60%
UNHUnitedHealth Group Incorporated Common Stock (DE)-5.33%-0.09%
TMOThermo Fisher Scientific Inc.+7.87%+0.83%
AMGNAmgen Inc.-5.52%+2.60%
GILDGilead Sciences Inc.-2.75%+1.82%
ABTAbbott Laboratories-8.86%+0.58%